Medicare Prescription Drug Price Negotiation Act of 2017

referredUnited States· United States Congress· EN

Introduced

4 January 2017

Last action

25 January 2017 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Sen. Welch, Peter [D-VT], Rep. Schakowsky, Janice D. [D-IL-9], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Cummings, Elijah E. [D-MD-7], Rep. Ellison, Keith [D-MN-5], Rep. Pocan, Mark [D-WI-2], Rep. Cicilline, David N. [D-RI-1], Rep. Kaptur, Marcy [D-OH-9], Rep. Lipinski, Daniel [D-IL-3], Rep. McCollum, Betty [D-MN-4], Rep. Castor, Kathy [D-FL-14], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Lynch, Stephen F. [D-MA-8], Rep. Cohen, Steve [D-TN-9], Rep. Lujan Grisham, Michelle [D-NM-1], Rep. Cartwright, Matt [D-PA-17], Rep. Deutch, Theodore E. [D-FL-22], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Raskin, Jamie [D-MD-8], Rep. Loebsack, David [D-IA-2], Rep. Huffman, Jared [D-CA-2], Rep. Gabbard, Tulsi [D-HI-2], Rep. Blumenauer, Earl [D-OR-3], Rep. Visclosky, Peter J. [D-IN-1], Rep. Sherman, Brad [D-CA-32], Rep. Pingree, Chellie [D-ME-1], Rep. DeFazio, Peter A. [D-OR-4], Rep. Sarbanes, John P. [D-MD-3], Rep. Suozzi, Thomas R. [D-NY-3], Rep. Lofgren, Zoe [D-CA-18], Rep. Garamendi, John [D-CA-8], Rep. Maloney, Sean Patrick [D-NY-18], Rep. Langevin, James R. [D-RI-2], Rep. Rooney, Francis [R-FL-19], Sen. Gallego, Ruben [D-AZ], Rep. Takano, Mark [D-CA-39], Rep. Rush, Bobby L. [D-IL-1], Rep. Payne, Donald M., Jr. [D-NJ-10], Rep. Jackson Lee, Sheila [D-TX-18], Rep. Ryan, Tim [D-OH-13], Rep. Doyle, Michael F. [D-PA-14], Rep. Khanna, Ro [D-CA-17], Rep. Wasserman Schultz, Debbie [D-FL-25], Sen. Luján, Ben Ray [D-NM], Rep. Ruiz, Raul [D-CA-25], Rep. Carbajal, Salud O. [D-CA-24]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Official source Download file View documents Share

Summary

Medicare Prescription Drug Price Negotiation Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

4 January 2017
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
4 January 2017
Introduced
Introduced in House
Source: IntroReferral
4 January 2017
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
4 January 2017
Introduced
Introduced in House
Source: IntroReferral
13 January 2017
Referred
Referred to the Subcommittee on Health.
Source: Committee
25 January 2017
Referred
Referred to the Subcommittee on Health.
Source: Committee

Votes

No vote records are attached yet.

Versions

Introduced in House · 4 January 2017 · Download file

Documents

3 official files

Introduced in House (text)

View file Download file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Introduced in House (text)
Introduced in House · EN · 4 January 2017
View Download Open at official source
Introduced in House (PDF)
Introduced in House · EN · 4 January 2017
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 4 January 2017
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

related to → Medicare Prescription Drug Price Negotiation Act of 2019
related to → Medicare Prescription Drug Price Negotiation Act of 2017
related to ← Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017
related to ← Medicare Buy-In and Health Care Stabilization Act of 2017
related to ← Medicare Prescription Drug Price Negotiation Act of 2015

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/115th-congress/house-bill/242
Open data entity: https://api.congress.gov/v3/bill/115/hr/242
us · 115-hr-242 · source updated 5 December 2025